Literature DB >> 12545045

Hemoadsorption therapy for sepsis syndromes.

John A Kellum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12545045     DOI： 10.1097/00003246-200301000-00060

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  5 in total

1.  Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.

Authors:  Zhi-Yong Peng; Hong-Zhi Wang; Melinda J Carter; Morgan V Dileo; Jeffery V Bishop; Fei-Hu Zhou; Xiao-Yan Wen; Thomas Rimmelé; Kai Singbartl; William J Federspiel; Gilles Clermont; John A Kellum
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

2.  In Silico Augmentation of the Drug Development Pipeline: Examples from the study of Acute Inflammation.

Authors:  Gary An; John Bartels; Yoram Vodovotz
Journal:  Drug Dev Res       Date:  2011-03-01       Impact factor: 4.360

Review 3.  Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.

Authors:  Robert S Parker; Gilles Clermont
Journal:  J R Soc Interface       Date:  2010-02-10       Impact factor: 4.118

4.  Effects of hemoadsorption on cytokine removal and short-term survival in septic rats.

Authors:  Zhi-Yong Peng; Melinda J Carter; John A Kellum
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

5.  Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial.

Authors:  Gordana Taleska Stupica; Maja Sostaric; Marija Bozhinovska; Lea Rupert; Zoran Bosnic; Ales Jerin; Alojz Ihan; Tomislav Klokocovnik; Matej Podbregar
Journal:  Cardiovasc Ther       Date:  2020-03-27       Impact factor: 3.023
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.